These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12643623)

  • 1. Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice.
    Watanabe N; Ikuta K; Okazaki K; Nakase H; Tabata Y; Matsuura M; Tamaki H; Kawanami C; Honjo T; Chiba T
    Dig Dis Sci; 2003 Feb; 48(2):408-14. PubMed ID: 12643623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal drug delivery systems with biodegradable microspheres targeting mucosal immune-regulating cells for chronic inflammatory colitis.
    Okazaki K; Nakase H; Watanabe N; Tabata Y; Ikada Y; Chiba T
    J Gastroenterol; 2002 Nov; 37 Suppl 14():44-52. PubMed ID: 12572865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of inflammatory bowel disease in a mouse model of depression.
    Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
    Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Acetylglucosaminyltransferase V exacerbates murine colitis with macrophage dysfunction and enhances colitic tumorigenesis.
    Shinzaki S; Ishii M; Fujii H; Iijima H; Wakamatsu K; Kawai S; Shiraishi E; Hiyama S; Inoue T; Hayashi Y; Kuwahara R; Takamatsu S; Kamada Y; Morii E; Tsujii M; Takehara T; Miyoshi E
    J Gastroenterol; 2016 Apr; 51(4):357-69. PubMed ID: 26349931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
    Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
    J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
    Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I
    Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of experimental colitis by intestinal mononuclear phagocytes.
    Qualls JE; Kaplan AM; van Rooijen N; Cohen DA
    J Leukoc Biol; 2006 Oct; 80(4):802-15. PubMed ID: 16888083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of experimental mouse models of inflammatory bowel disease.
    Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
    Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restraint stress induces and exacerbates intestinal inflammation in interleukin-10 deficient mice.
    Koh SJ; Kim JW; Kim BG; Lee KL; Kim JS
    World J Gastroenterol; 2015 Jul; 21(28):8580-7. PubMed ID: 26229400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New cytokine delivery system using gelatin microspheres containing interleukin-10 for experimental inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Ozeki M; Watanabe N; Ohana M; Uose S; Uchida K; Nishi T; Mastuura M; Tamaki H; Itoh T; Kawanami C; Chiba T
    J Pharmacol Exp Ther; 2002 Apr; 301(1):59-65. PubMed ID: 11907157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system.
    Komiyama Y; Andoh A; Fujiwara D; Ohmae H; Araki Y; Fujiyama Y; Mitsuyama K; Kanauchi O
    Scand J Gastroenterol; 2011 Jan; 46(1):40-52. PubMed ID: 20735154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of guggulsterone against colitis are associated with the suppression of TREM-1 and modulation of macrophages.
    Che X; Park KC; Park SJ; Kang YH; Jin HA; Kim JW; Seo DH; Kim DK; Kim TI; Kim WH; Kim SW; Cheon JH
    Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G128-G139. PubMed ID: 29543509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
    Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
    J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy.
    Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Matsushima Y; Kawanami C; Oshima C; Ikada Y; Chiba T
    J Pharmacol Exp Ther; 2000 Jan; 292(1):15-21. PubMed ID: 10604927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.
    Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X
    Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of colon inflammation by CD80 blockade: evaluation in two murine models of inflammatory bowel disease.
    Eri R; Kodumudi KN; Summerlin DJ; Srinivasan M
    Inflamm Bowel Dis; 2008 Apr; 14(4):458-70. PubMed ID: 18186109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid development of colitis in NSAID-treated IL-10-deficient mice.
    Berg DJ; Zhang J; Weinstock JV; Ismail HF; Earle KA; Alila H; Pamukcu R; Moore S; Lynch RG
    Gastroenterology; 2002 Nov; 123(5):1527-42. PubMed ID: 12404228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin Deficiency Accelerates Spontaneous Colitis in Mice with Disrupted Gut Microbiota and Macrophage Phagocytic Activity.
    Toyonaga T; Nakase H; Ueno S; Matsuura M; Yoshino T; Honzawa Y; Itou A; Namba K; Minami N; Yamada S; Koshikawa Y; Uede T; Chiba T; Okazaki K
    PLoS One; 2015; 10(8):e0135552. PubMed ID: 26274807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a novel IL-10 deficient cell transfer model for colitis.
    Ikenoue Y; Tagami T; Murata M
    Int Immunopharmacol; 2005 Jun; 5(6):993-1006. PubMed ID: 15829415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.